Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.75%
- Poor long term growth as Net Sales has grown by an annual rate of -7.11% and Operating profit at -154.52% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Sep 25
3
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.01%
0%
-18.01%
6 Months
22.0%
0%
22.0%
1 Year
24.49%
0%
24.49%
2 Years
20.08%
0%
20.08%
3 Years
-9.5%
0%
-9.5%
4 Years
-18.67%
0%
-18.67%
5 Years
-6.15%
0%
-6.15%
Shenzhen Neptunus Bioengineering Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-7.11%
EBIT Growth (5y)
-154.52%
EBIT to Interest (avg)
0.55
Debt to EBITDA (avg)
21.96
Net Debt to Equity (avg)
4.87
Sales to Capital Employed (avg)
2.06
Tax Ratio
6.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.75%
ROE (avg)
2.85%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.57
EV to EBIT
-171.79
EV to EBITDA
90.95
EV to Capital Employed
1.47
EV to Sales
0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.85%
ROE (Latest)
-40.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
7,201.40
6,935.90
3.83%
Operating Profit (PBDIT) excl Other Income
185.40
238.00
-22.10%
Interest
147.10
150.50
-2.26%
Exceptional Items
0.10
0.00
Consolidate Net Profit
3.40
11.90
-71.43%
Operating Profit Margin (Excl OI)
25.70%
26.50%
-0.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.83% vs -5.96% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -71.43% vs -77.55% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
30,266.10
36,356.50
-16.75%
Operating Profit (PBDIT) excl Other Income
423.00
700.30
-39.60%
Interest
850.90
992.40
-14.26%
Exceptional Items
-471.40
-909.60
48.18%
Consolidate Net Profit
-1,167.30
-1,719.00
32.09%
Operating Profit Margin (Excl OI)
5.40%
11.10%
-0.57%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -16.75% vs -3.74% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 32.09% vs -73.39% in Dec 2023
About Shenzhen Neptunus Bioengineering Co., Ltd. 
Shenzhen Neptunus Bioengineering Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






